Tiotropium (LAMA)
Treatment for Emphysema
Typical Dosage: 18 mcg once daily
Effectiveness
70%
Safety Score
65%
Clinical Trials
1
Participants
50K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
18 mcg once daily
Time to Effect
within 30 minutes
Treatment Duration
lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
12(Treat 12 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
7(Treat 7 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$5,000
Monitoring:$800
Side Effect Mgmt:$100
Total Annual:$5,900
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$50,000/QALY
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$9,077
Tiotropium (LAMA) Outcomes
for Emphysema
Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+65%
Common Side Effects
Dry mouth
+15%
Upper respiratory tract infection
+4.5%
Pharyngitis
+2%
Sinusitis
+1.5%
Urinary tract infection
+1.5%
Dyspepsia
+1.5%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
1 completed trial for Tiotropium (LAMA) in Emphysema
A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator
NCT01794780COMPLETEDPHASE4
2.23K participants
INTERVENTIONAL
Beijing, China +1 more
Started: Feb 5, 2013